Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
about
Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infectionEfficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndromeUse of rifaximin in gastrointestinal and liver diseasesMoxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNew and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsDiagnosis and treatment of diarrhea-predominant irritable bowel syndromeDiagnosis and management of functional symptoms in inflammatory bowel disease in remissionPsychosocial impact of irritable bowel syndrome: A brief reviewUpdate on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and OutlookValidation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review.Reversal of Irritable Bowel Syndrome, Sleep Disturbance, and Fatigue With an Elimination Diet, Lifestyle Modification, and Dietary Supplements: A Case ReportThe utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysisProbiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Colonic transit time and IBS symptoms: what's the link?Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.Importance of early diagnosis in patients with irritable bowel syndrome.Pelvic floor disorders and quality of life in women with self-reported irritable bowel syndrome.Travel and travelers' diarrhea in patients with irritable bowel syndromeOverlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptomsImpact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspectiveComparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.Effects of NB001 and gabapentin on irritable bowel syndrome-induced behavioral anxiety and spontaneous pain.High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome.The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.Trauma history and risk of the irritable bowel syndrome in women veterans.Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?Functional bowel disorders in Iranian population using Rome III criteria.Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.The current prevalence of irritable bowel syndrome in AsiaExtending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms.Post-traumatic Stress Disorder Is Associated With Irritable Bowel Syndrome in African Americans.Dietary fructose intolerance, fructan intolerance and FODMAPs.Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.
P2860
Q21198942-F6234ABE-5F71-495E-82D0-0B5FA339C96BQ24684839-38084615-111D-451B-BFAA-8577466F341DQ26740201-FA8B2289-E5E8-4944-B32D-07D79A80DCB6Q26746961-74C51AB4-7EB7-47D9-9421-12E2EDACA88AQ26748617-90A6D145-4A9B-48B2-98BE-94450B1EE1B7Q26765272-E790C619-EC9E-4704-B361-55D7AB5E3673Q26768264-98498011-51CB-41AE-A992-3F98A02C59CAQ26776175-7C6014BA-D0ED-4916-83C8-90EF7EC2E5E1Q26995945-76466E3D-B32C-4B2E-8594-1D260E9CEE5FQ27687488-3CB423C9-546A-4AC2-89CA-2442F3A6FE93Q28817748-47A014DC-A9FB-478C-8549-34D9E2A621BBQ30574620-1679E2C9-C2DA-4616-811E-C453FB6134FFQ30575444-7259B7E7-7550-414E-9845-00E2595D082AQ31131851-271A37FA-ED37-4CA3-886F-7F5AA1F7E46CQ33449885-67F1A53F-277E-4014-A29F-A8805582E56EQ33451900-4F3C6901-8010-4ED5-B58B-3802A446D2D5Q33453362-30D7F69A-100E-4C58-9C8F-BB8A4460195EQ33455352-3E4754F2-D478-4136-9177-1D6A77850327Q33458071-7BFC4388-7486-4439-9DF1-5E762EC0726EQ33527597-E0CE4CC4-D4B4-45AD-8E15-CF1E655A094FQ33536973-6BB3761D-F934-4FC0-9BC5-17D6D48C3CE4Q33596337-7F9F28D7-6F62-4A44-A4DE-DB6BF8340991Q33617616-C143F6C5-AFE7-4298-B935-A1CC583AD02CQ33730271-9EEC6E8A-5C3F-45FA-A272-9EF89671C956Q33768802-5EEEECCA-0D0F-4F14-ADDF-D71C80AFD5BBQ33781168-0F6DF315-DC8F-4568-B5E0-20182E75BA8BQ33807470-F4C9111B-0DFF-4A67-B18A-47C6DE5705CEQ33873584-AE2459F7-6E2A-4FA2-8BAB-8E3DE53905A8Q33919373-9AEFB081-31D3-4C0D-BA7D-23A892B83414Q34005405-7877A29D-CC36-4770-88B4-B09E6ABEA71CQ34016819-C3884522-16D0-4545-BA7A-0CC617947C7EQ34101503-65B26673-573D-4DB9-9D53-4F7B1F70C12FQ34125100-79D9246D-290A-4467-B3CA-1C8E673F2F96Q34129435-714C7C0F-737F-4A0D-9B55-2F69B42FF03BQ34179472-F93D9044-F6DB-4FD6-85CB-CA6D0B464647Q34298271-2018075C-6813-4521-B3C7-32B3109E0BCBQ34341087-5B4305CD-9790-4742-9A9A-708033E3214DQ34377163-CCD341CF-FBC2-476F-88F5-B10DDD96112FQ34393301-124395AF-452A-4B14-AB7E-99B45381318AQ34409173-A6938C19-2523-4835-A336-5DA367DC7019
P2860
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@ast
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@en
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@nl
type
label
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@ast
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@en
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@nl
prefLabel
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@ast
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@en
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
@nl
P2093
P2860
P1476
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2005.02463.X
P407
P577
2005-06-01T00:00:00Z